„Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway“. Nigerian Journal of Physiological Sciences, Bd. 40, Nr. 2, Dezember 2025, S. 251-62, https://doi.org/10.54548/.